News

Cephalon will assume all expenses for Phase III studies, regulatory filings and subsequent commercialization of the product. ImmuPharma has received a $15 million upfront fee at the initiation

During his period, Rava led the research, development and manufacturing scale-up of the Affymetrix’ GeneChip technology. He was incharge for the delivery of multiple products involving complex assays,

In the EU, Abraxane is indicated for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing

Under the terms of the agreement, the transaction includes an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones. Operating within

Specifically, Biofield has acquired the exclusive worldwide distribution rights outside of Belgium, for ValiRx’s human papilloma virus diagnostic test for cervical cancer as well as for ValiRx’s HyperGenomics

To date, Diffusion Pharmaceuticals has raised $13.1 million in private equity and has received $2.6 million in government R&D funding from the Office of Naval Research, bringing the

Eisai has said that the Travelmin churop grape flavor prevents and alleviates symptoms of motion sickness such as dizziness and nausea with antihistaminic component (d-chlorpheniramine maleate) and anticholinergic

Dr Durnell has been with Gentel for over a year where he served as the vice president of commercial operations. In his new role, Dr Durnell will be

Under the terms of the agreement, Trevena has received exclusive worldwide rights to sublicense active compounds resulting from the collaboration. Ligand expects to screen 24 targets over two